معرفی
John Stendahl, MD, PhD, is an Assistant Professor of Medicine in the Department of Internal Medicine at Yale School of Medicine, specializing in Cardiovascular Medicine. He is a key member of the Cardiomyopathy & Inherited Cardiovascular Disease Program and affiliated with the Yale Biomedical Imaging Institute and the Yale Translational Research Imaging Center (Y-TRIC). His work integrates clinical cardiology with advanced imaging and translational research.
- Assistant Professor of Medicine (Cardiovascular Medicine), Yale School of Medicine
- Member, Cardiomyopathy & Inherited Cardiovascular Disease Program
- Affiliated Faculty, Yale Biomedical Imaging Institute
- Member, Yale Translational Research Imaging Center (Y-TRIC)
Dr. Stendahl holds an MD from the University of Minnesota (2011) and a PhD in Materials Science and Engineering from Northwestern University (2005), with undergraduate training also from the University of Minnesota. His interdisciplinary background enables a unique approach to cardiovascular diagnostics and therapeutics.
- MD, University of Minnesota, 2011
- PhD, Materials Science and Engineering, Northwestern University, 2005
- BS, Materials Science and Engineering, University of Minnesota, 1999
His research focuses on hypertrophic cardiomyopathy (HCM), cardiovascular imaging, and inherited heart diseases. He employs advanced techniques such as SPECT, PET, CT, and molecular imaging to improve diagnosis and management. His work includes genetic analysis, risk stratification, and clinical trials for novel therapies. He is particularly interested in sex-specific outcomes, genotype-phenotype correlations, and the long-term impact of interventions like septal reduction.
The analysis of his recent publications reveals a strong emphasis on clinical and translational research in HCM. His work leverages large registries such as the Sarcomeric Human Cardiomyopathy Registry (SHARE) to investigate risk factors, disease progression, and treatment outcomes. There is a clear trend toward integrating genetic data with imaging and clinical phenotypes to enable precision medicine approaches in cardiomyopathy.
Dr. Stendahl has been recognized for his research with a Career Development Award from the National Heart, Lung, and Blood Institute (NHLBI) in 2022.
- Career Development Award, NHLBI, 2022
He actively contributes to academic service, having served as a reviewer for journals including the Journal of Nuclear Medicine, American Heart Journal, Nanomedicine, and Journal of Applied Physiology. His collaborative research network includes prominent Yale investigators such as Albert Sinusas, James Duncan, and Lawrence Staib, reflecting a strong interdisciplinary approach. He is also a member of the Janeway Society, highlighting his role as a physician-scientist at Yale.
Dr. Stendahl is affiliated with multiple research teams and centers focused on cardiovascular innovation, including the Yale Biomedical Imaging Institute and Y-TRIC, where he contributes to the development and application of cutting-edge imaging technologies for heart disease.